表纸
市场调查报告书
商品编码
1024236

绿茶萃取物(EGCG):营养补充品,化妆品,医药品领域的机会评估(2021年下半年)

Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H2 2021

出版日期: | 出版商: GervanoRA Data Services LLP | 英文 103 Pages | 商品交期: 3-5个工作天内

价格
  • 全貌
  • 简介
  • 目录
简介

本报告提供绿茶萃取物(EGCG)市场调查,除了评估营养补充品·化妆品·医药品领域的机会以外,更汇整产业趋势,市场成长要素及阻碍因素分析,未满足需求,开采技术的趋势,竞争情形,主要企业分析等资料。

目录

第1章 简介

第2章 摘要整理

第3章 绿茶萃取物概要

第4章 绿茶开采技术

第5章 绿茶萃取物的机会评估

第6章 医药品·营养补充品·化妆品临床开发

第7章 竞争市场区隔概要

第8章 简称

目录
Product Code: GERPH1312

The 'Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H2 2021' report provides in-depth insights with respect to the three major applications and is built to provide strategically important competitor information, analytics, and insights to formulate effective counter research and development strategies. The report offers comprehensive analytics on GTE competitive space by covering nutraceuticals, cosmetics and pharmaceutical segments to assess the unmet needs, drivers, restrains and opportunities.

The following segments provide detailed analytics covering the overall GTE competitive space:

  • Key Events in GTE competitive space
  • Major Drivers, Restraints and Unmet Needs & Opportunities
  • GTE Industry overview
  • Developments and Trends in its Extraction Technologies
  • End Use Opportunity Assessment
  • Clinical Developments
  • Competitive Landscape of Companies
  • Key Companies SWOT Analysis

Report is concentrated more on providing the future favorable opportunities and growth that can be expected in the Green Tea Extract (GTE) market.

TABLE OF CONTENTS

1. INTRODUCTION

2. EXECUTIVE SUMMARY

3. GREEN TEA EXTRACT OVERVIEW

4. GREEN TEA EXTRACT TECHNOLOGIES

5. GREEN TEA EXTRACT OPPORTUNITIES ASSESSMENT (END USE OR APPLICATION SEGMENT)

6. CLINICAL DEVELOPMENTS IN PHARMACEUTICALS, NUTRACEUTICALS, COSMETICS

7. OVERVIEW OF COMPETITIVE SEGMENT

8. ABBREVIATIONS

LIST OF TABLES

  • TABLE 01: UNIVERSITIES AND INSTITUTES IN GTE RESEARCH
  • TABLE 02: EGCG OPPORTUNITIES IN OBESITY CONTROL
  • TABLE 03: EGCG OPPORTUNITIES IN ONCOLOGY
  • TABLE 04: EGCG OPPORTUNITIES IN DIABETES
  • TABLE 05: EGCG OPPORTUNITIES IN NEURODEGENERATIVE DISEASES
  • TABLE 06: EGCG OPPORTUNITIES IN LIVER DISEASES
  • TABLE 07: ASSESSMENT OF STUDIES FOR EGCG OPPORTUNITIES IN NUTRACEUTICALS
  • TABLE 08: OPPORTUNITY FINDINGS OF EGCG IN COSMETICS
  • TABLE 09: EGCG APPLICATIONS IN ONCOLOGY
  • TABLE 10: EGCG APPLICATIONS IN CARDIOVASCULAR DISEASES
  • TABLE 11: EGCG APPLICATIONS IN METABOLIC DISORDERS
  • TABLE 12: EGCG APPLICATIONS IN INFLAMMATROY SKIN DISEASES
  • TABLE 13: EGCG APPLICATIONS IN NEURODEGENERATIVE DISEASES
  • TABLE 14: EGCG APPLICATIONS IN OBESITY
  • TABLE 15: CLINICAL TRIALS IN PHARMACEUTICALS
  • TABLE 16: CLINICAL TRIALS IN NUTRACEUTICALS

LIST OF FIGURES

  • FIGURE 01: PAST EVENTS IN THE GTE PHARMACEUTICAL MARKET SPACE, 2006 TILL DATE
  • FIGURE 02: FUTURE ESTIMATED PIPELINE MOLECULE APPROVALS
  • FIGURE 03: KEY EVENTS IN THE NUTRACEUTICAL MARKET SPACE
  • FIGURE 04: KEY EVENTS IN THE COSMETICS MARKET SPACE
  • FIGURE 05: TRADITIONAL GREEN TEA EXTRACTION TECHNIQUES
  • FIGURE 06: ADVANCED GREEN TEA EXTRACTION TECHNOLOGIES
  • FIGURE 07: EGCG OPPORTUNITIES IN COSMETICS
  • FIGURE 08: INDENA MARKET OVERVIEW, GLOBAL
  • FIGURE 09: ANNUAL REVENUES (FY ENDED MARCH IN $M), TATE AND LYLE
  • FIGURE 10: ANNUAL REVENUES BY BUSINESS SEGMENTS, TATA AND LYLE
  • FIGURE 11: ANNUAL REVENUES SHARE OF BUSINESS SEGMENTS, DSM
  • FIGURE 12: DSM SALES BY DESTINATION REGIONS